STEPHEN D SAWRUK
Chiropractic in Lacey Township, NJ
License number
New Jersey 38MC00156000
Issued Date
Nov 17, 1976
Expiration Date
Aug 31, 1999
Category
Chiropractic Examiners
Type
Chiropractor
Address
Address
Lacey Township, NJ
Professional information
Infra-Red Stealth Masking Device (Irsmd)
US Patent:
6098402, Aug 8, 2000
Filed:
Jan 22, 1990
Appl. No.:
7/468123
Inventors:
Stephen D. Sawruk - Lanoka Harbor NJ
International Classification:
F02K 1100
US Classification:
60267
Abstract:
An Infra-Red suppression device composed of systems designed to alter the infra-red spectrum bands produced by the exhaust plume and airframe friction in order to render infra-red seekers, both active and passive, and infra-red homing missiles ineffective, therefore substantially increasing air-craft and crew survivability, and the BET or battle extension time.
Fragmentation Device
US Patent:
4942820, Jul 24, 1990
Filed:
Jul 18, 1989
Appl. No.:
7/381193
Inventors:
Stephen D. Sawruk - Lanoka Harbor NJ
International Classification:
F42B 2700
US Classification:
102482
Abstract:
A fragmentation device includes a core of munitions in the form of a sphere. The sphere of munitions is surrounded by a spherical outer shell of a rubberized material. Further provide is a fuze at the surface of the internal rubberized material which is an electrical communication with a detonator which is embedded within the spherical core of munitions. The rubberized spherical shell is provided with spherically symmetrical fractures which radiate out from the core to insure a symmetrical dispersion of the force associated with the detonated munitions core.
Method For Treatment Of Osteoporosis
US Patent:
5478579, Dec 26, 1995
Filed:
Jul 21, 1993
Appl. No.:
8/095738
Inventors:
Stephen Sawruk - Lanoka Harbor NJ
Assignee:
Biodyn Medical Research, Inc. - Nutley NJ
International Classification:
A01N 4304, A61K 31715, C07H 1500, C07G 300
US Classification:
424535
Abstract:
A method for orally inducing and enhancing the absorption of calcium into mammalian bone tissue comprises the administration of an effective dose of a flavonol aglycone glycoside in combination with nutritional calcium. Various herbal sources are shown. Potassium gluconate may be added to the system as an adjuvant.